# 3i, LP — capital_raise/public_offering [announced]
Source: SEC API (secapi.ai) · situation sit_eb8dbe20c397d2e1eeb4 · retrieved 2026-08-11T15:50:51.137Z

## Overview
Valion Bio, Inc. is a pharmaceutical preparations company (formerly known as Tivic Health Systems, Inc.).

3i, LP, a significant shareholder holding 9.9% of Valion Bio, Inc. (formerly Tivic Health Systems), delivered a letter to the company's board of directors on July 29, 2026, demanding the immediate removal of Chief Executive Officer Michael Handley and the commencement of a search for his replacement. The letter asserts that the board has failed in its fiduciary duties by allowing Handley's "sustained mismanagement" to continue destroying shareholder value, and states that 3i reserves all rights available to shareholders, including those under applicable corporate law, should the board fail to act promptly.

## Terms
- Counterparty: Valion Bio, Inc. · Stake: 9.9%

## Key dates
- Announced 2026-08-03

## Timeline
- 2026-08-03 · SCHEDULE 13D (0001753926-26-001299): SCHEDULE 13D - 3i, LP — *Valion Bio, Inc. is a pharmaceutical preparations company (formerly known as Tivic Health Systems, Inc.).* 3i, LP, a significant shareholder holding 9.9% of Valion Bio, Inc. (formerly Tivic Health Systems), delivered a letter to the company's board of directors on July 29, 2026, demanding the immediate removal of Chief Executive Officer Michael Handley and the commencement of a search for his replacement. The letter asserts that the board has failed in its fiduciary duties by allowing Handley's "sustained mismanagement" to continue destroying shareholder value, and states that 3i reserves all rights available to shareholders, including those under applicable corporate law, should the board fail to act promptly.
  https://www.sec.gov/Archives/edgar/data/1841619/0001753926-26-001299.txt

## Citations
- 0001753926-26-001299 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000175392626001299